Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ImmuCell Corp

+ Add to Watchlist


7.3000 USD 0.1000 1.39%

As of 20:10:00 ET on 05/28/2015.

Snapshot for ImmuCell Corp (ICCC)

Open: 7.2000 Day's Range: 6.9800 - 7.3000 Volume: 24,170
Previous Close: 7.2000 52wk Range: 3.8700 - 8.6900 1-Yr Rtn: +69.37%

Stock Chart for ICCC

No chart data available.
  • ICCC:US 7.3000
  • 1D
  • 1M
  • 1Y
Interactive ICCC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ICCC

Current P/E Ratio (ttm) 81.1111
Estimated P/E(-) -
Relative P/E vs. SPX 4.3301
Earnings Per Share (ttm) 0.0900
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 22.11
Shares Outstanding (M) 3.03
30 Day Average Volume 24,848
Price/Book (mrq) 2.3867
Price/Sale (ttm) 2.5644
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ICCC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ICCC

ImmuCell Corporation is a biotechnology company which develops and manufactures milk-derived passive antibody products. The Company's products prevent and/or treat gastrointestinal infections in humans and animals. ImmuCell also, through joint ventures, entered into a UK distribution agreement to market Crypto-Scan, a drinking-water test, and is also manufacturing bovine lactoferrin.

Michael F BrighamPresident/CEO/Treasurer/SecyJoseph H CrabbVP/Chief Scientific Officer
John W ZinckgrafDirector:Product Development
More Company Profile & Key Executives for ICCC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil